Bonalive Biomaterials
Marika Ojala serves as Quality Director at Bonalive Biomaterials since December 2021, previously holding the role of Quality Manager. Prior experience includes positions as a QA Specialist at Biovian and Electro Optical Systems, and Quality and Clinical Research Manager at Ocuspecto Oy. Ojala also worked as Preclinical Manager at Biotie Therapies Corp. from 1999 until September 2013. Educational qualifications include a Master's degree in Biotechnology from the University of Jyväskylä and an Engineer's degree in Biotechnology from Turun AMK, along with additional studies in Sports Medicine at Itä-Suomen yliopisto.
This person is not in any teams
Bonalive Biomaterials
As the world seeks answers to the growing threat of antibiotic resistance, Bonalive represents a new standard in patient care. Evolving at the intersection of technology and human biology, our Smart Healing™ technologies reduce antibiotic treatments and enable a better quality of life for patients. Smart Healing™ encompasses our commitment to our customers. It defines everything we do, in providing patients and surgeons well-proven and safe bone regenerative products in orthopedics, trauma, spine, septic bone and ear surgery. It's time to heal smarter. #SmartHealing For indications, contraindications, warnings and precautions related to Bonalive® products refer to the IFU within the product package. This site is not intended for US customers.